When a UK startup gains early traction, the temptation to "flip" to the US is real. Silicon Valley offers denser networks of venture capital, larger exit multiples, and access to the most valuable customer base on Earth. But for founders who've built SEIS or EIS-backed companies in the UK, relocation triggers a hard question: can you move your legal domicile to Delaware, carry your UK investors along, and keep the tax relief flowing?

The short answer: it's legally possible, but the tax relief implications are complex, the timing matters enormously, and you need specialist advice before you move.

This guide walks through the structural mechanics, HMRC rules, investor expectations, and the practical tradeoffs founders face when considering a transatlantic flip.

Understanding the SEIS and EIS Tax Relief Regimes

Before exploring the flip scenario, it's essential to recall what SEIS and EIS actually protect.

SEIS (Seed Enterprise Investment Scheme) offers UK individuals income tax relief of 50% on investments up to £100,000 per tax year in eligible shares. Investors can claim losses against other income. The scheme targets very early-stage companies—most commonly pre-revenue or early-revenue businesses with less than 2 years' trading history and gross assets under £200,000.

EIS (Enterprise Investment Scheme) provides 30% income tax relief on investments up to £1 million per year, plus capital gains tax exemption on gains within the fund, and loss relief. It targets slightly more mature companies—typically post-revenue, less than 10 years old, fewer than 50 employees, and annual turnover under £30 million (at investment date).

Both schemes exist to incentivise UK high-net-worth individuals and institutions to fund early-stage risk. The tax relief is tied to the investor's UK tax residency and to the company's UK tax residency. That's the crux.

What Happens to Tax Relief When You Move the Company?

The moment you relocate your company's tax residency to the US (typically by incorporating a new US entity and causing the UK company to be a subsidiary or by a merger), the SEIS/EIS relief mechanism begins to unwind.

HMRC's Core Requirement: UK Residency

Both SEIS and EIS require the company to be a UK-resident company for corporation tax purposes. HMRC's EIS guidance explicitly states that relief is only available in respect of shares in a UK resident company. The same rule applies to SEIS.

If you relocate to the US and become a US tax resident (incorporated and managed from Delaware or California), HMRC will no longer treat you as a UK-resident company. Your existing investors will lose eligibility to claim relief on new investments into the relocated entity. More critically, HMRC's stance on post-investment migration is that if a company previously EIS-qualifying ceases to be UK-resident, the relief already claimed by investors remains valid (it doesn't claw back retroactively), but any further capital raises into the US entity are not EIS-eligible.

The Relief Clawback Risk

There is a narrower risk of clawback. If a company has received EIS/SEIS investment and within three years of investment it ceases to be UK-resident, or it carries on a non-UK trade, or it acquires a non-UK company without proper clearance, HMRC can withdraw relief. The investor's tax relief can be clawed back, and the company may face assessments.

However, in practice, many transatlantic flips that happen 3+ years post-investment (and post-relief claim) face less clawback risk because the statutory lookback period has elapsed. This is an important timing consideration.

Structural Options: How Founders Attempt to Flip While Preserving Investor Status

In practice, founders use one of several structures to navigate this tension. None are perfect; all require HMRC pre-clearance or careful documentation.

Option 1: The Dual-Structure Model

Keep a dormant UK company (or a UK operating holdco) for tax and investor purposes, and create a separate US operating company (Delaware C-corp) that holds the actual IP and operations. UK investors remain shareholders in the UK entity, which holds shares in the US entity as a subsidiary.

Pros: The UK company remains UK-tax-resident, so EIS/SEIS relief arguments remain valid for future funding rounds into the UK company. Investors' existing relief is unaffected.

Cons: Creates complexity, a double tax layer (UK company tax on UK income, plus US corporate tax on the US subsidiary), and potential transfer pricing scrutiny from HMRC if you're shifting all IP and revenue to the US entity. Over time, the UK company becomes a shell, and the economic substance argument weakens.

Option 2: The Merger and Regrant

Your UK company merges into a US parent; UK investors become shareholders in a US holding company. This is a formal legal flip.

Pros: Clean structure, operational simplicity—one entity, one board, one cap table.

Cons: You've created a non-UK-resident company. Any new SEIS/EIS investment is ineligible. You must notify HMRC of the migration, and if your investment has been claimed within 3 years, there is clawback risk unless you have a shareholder clearance from HMRC in advance. Few founders obtain this clearance, as it requires explicit written permission from HMRC and evidence of commercial substance.

Option 3: The Section 106 ICTA 1988 Election (The "No Relief" Path)

If you know you're going to flip, some founders have pre-emptively elected out of SEIS/EIS entirely in earlier rounds and raised on a commercial (non-relief-backed) basis. Subsequent investors are simply equity investors with no tax relief. This removes the HMRC trigger.

Pros: No clawback risk. Clean separation between relief and non-relief capital.

Cons: You've left money on the table—investors will demand lower share price or higher discount to compensate for lost tax relief. Early-stage funding becomes harder and more expensive.

Practical Case: The Timeline and Investor Perspective

A typical timeline illustrates the tension:

  1. Year 1 (Seed): You raise £500k under SEIS into a UK company. Five investors claim 50% relief (£250k in total income tax deductions). Your company remains UK-resident and trading.
  2. Year 2 (Series A): You raise £2m under EIS into the same UK company. Ten new investors claim 30% relief (£600k in total relief). You're now ~20 employees, UK-based operations, but with US clients and considering US expansion.
  3. Year 3 (Growth): A US strategic partner offers acquisition or a major US VC offers investment with a condition: relocate to Delaware, establish US management, restructure cap table to US standard. You decide to flip.
  4. Post-flip: The SEIS investors (Year 1) are now ~2 years out from investment; clawback risk is minimal if HMRC can't prove you were planning to move all along. But the Series A investors (Year 2) are only ~1 year post-investment; clawback risk is material. Neither cohort can make a new EIS investment into your US entity.

From an investor's perspective, this is a problem. Your early-stage investors were promised equity upside plus tax relief. The flip preserves the upside (they still own shares in the US company, via the holding structure), but it terminates the tax relief regime, which means they've lost a material economic benefit they paid for. Some investors sue. Others negotiate a discount on future rounds as compensation. Many simply accept the loss and move forward.

This is why many UK VCs and syndicates now include explicit language in their term sheets: "SEIS/EIS relief will not be claimed or transferred if the company relocates outside the UK within 3 years of investment." This shifts the risk squarely onto the founder's shoulders and signals realism about the likelihood of a successful exit.

HMRC Rules on Company Migration and Trade

HMRC publishes guidance on what constitutes a "migration" and when relief is at risk. The key trigger is a change in the company's UK tax residency. A company is UK tax-resident if:

  • It is incorporated in the UK, OR
  • Its central management and control is in the UK.

If you incorporate a new US entity and transfer your shareholders and operations, you've clearly triggered a move in both tests. If you keep the UK company as a legal entity but move all management to the US, HMRC may argue you've moved central management and control offshore, even if the company is still nominally UK-incorporated.

HMRC's guidance on statutory residence is primarily focused on individuals, but the central management and control test also applies to companies. You should obtain a tax opinion from a specialist firm (BDO, Deloitte, Grant Thornton, etc.) confirming your structure's residency before you move.

When Can You Safely Flip Without Clawback Risk?

Clawback risk diminishes over time. The EIS and SEIS regulations allow HMRC to claw back relief if the company ceases to be UK-resident within 3 years of the investment. If your investment was claimed 3+ years prior, and you've clearly operated as a UK company in the interim, a flip is less legally vulnerable (though not risk-free).

Practical rule of thumb: If you can wait 36+ months between your last EIS/SEIS funding round and your planned flip, you significantly reduce HMRC's ability to clawback. Founders aware of this often time their US expansion announcements deliberately post the 3-year mark.

However, this is not a legal guarantee. HMRC can still argue fraud or misrepresentation if it can show you were always planning a US move and misled investors into EIS/SEIS claims. Conversely, if your company has legitimately traded in the UK for 3+ years and grown organically, a change in strategy to expand to the US is viewed as normal business evolution.

Options for Continuing to Raise From UK Investors Post-Flip

If you've relocated to the US, you're not locked out of UK capital entirely. But your options shift:

Raise Commercially (Non-Relief-Backed)

Your UK investors—particularly if they're angel networks or syndicates familiar with US tech—may continue to invest without claiming SEIS/EIS relief. They structure it as a commercial equity investment into a US entity, likely via a US holding company or preferred shares. Returns and risk remain the same; the tax relief is simply surrendered. You'll likely need to offer a discount or better terms to compensate.

Establish a UK Operating Subsidiary

Some founders create a new UK company post-flip to retain UK operating activities (e.g., UK customers, UK R&D, UK IP licensing). They fundraise into this new UK subsidiary under EIS. However, this is legally fraught: HMRC scrutinizes whether the UK subsidiary is a genuine operating entity or merely a tax-relief arbitrage vehicle. If all real value and IP reside in the US, HMRC will argue the UK company is not genuinely trading. You'd need substantial UK payroll, real UK contracts, and UK capital investment to make this credible.

Leverage Accelerators and Grants

Post-flip, you may no longer be eligible for SEIS/EIS, but you could be eligible for Innovate UK grants, Horizon Europe funding (if UK-EU research collaboration), or regional development funds. These have different (and often less stringent) residency requirements and can supplement private capital. However, most grants require the company to be UK-incorporated and trading in the UK, so this pathway is often limited for a US-flipped company.

Tax Treaty Considerations

If you're a UK founder with a US company, and you still hold founder shares, you'll be subject to tax in both jurisdictions. The US-UK tax treaty prevents double taxation on certain items (dividends, capital gains), but it requires you to understand your filing obligations in both countries. Specifically:

  • UK tax: You remain a UK tax resident (if you're a UK-domiciled individual) and must pay UK tax on your worldwide income and gains, including gains on your US company shares. However, you may claim relief for US taxes paid under the treaty.
  • US tax: If you're a US citizen, you're taxed on worldwide income. If you're a UK citizen (non-US), you're only taxed on US-source income and gains from the company if you're a US tax resident or if the company qualifies as a US trade or business. The treaty then allocates the taxing rights.

This is why founders often work with cross-border tax advisors (KPMG, EY, PwC, or specialist boutiques like Gowling WLG) before and after a flip. You can end up paying tax in both jurisdictions if you're not careful, or you can optimize through entity structure and tax residency planning. But there is no free lunch—the regulations are tight.

The flip-and-raise scenario has become increasingly common since 2020, as UK founders have gained confidence in accessing US capital markets and as US VCs have become more comfortable with UK-founded companies. However, investor attitudes have shifted:

  • Later-stage VCs (Series B+) expect flips and don't care about SEIS/EIS relief. Their return expectations are predicated on US market access and US revenue; UK tax relief is irrelevant at that scale.
  • Early-stage syndicates and angels are more cautious. They've been burned by flips that destroyed relief claims, and they now price in the loss of tax relief as a risk factor. Some syndicates now require founders to commit to UK residency for a minimum period (e.g., 3-5 years) as a condition of SEIS/EIS investment.
  • Institutional EIS funds (like Fuel Ventures, Ada Ventures, SFC Capital) have developed clearer guidelines: they'll invest in UK companies that may eventually flip, but they reserve the right to clawback or demand indemnity if the flip happens within a specified window.

The trend is toward transparency and risk-sharing. Founders and early investors are now more explicit upfront about the likelihood and timeline of a potential US flip, and they factor that into the deal economics.

Practical Checklist: Should You Flip?

Before committing to a transatlantic move, ask yourself:

  1. How old are my last SEIS/EIS investments? If 3+ years old, clawback risk is lower. If younger, you're at higher risk.
  2. Have I obtained HMRC clearance or an advance tax opinion on my planned structure? If not, budget £10k–£30k for a specialist firm to review your proposed flip and provide a legal opinion. This protects you against surprise assessments later.
  3. Will my current UK investors accept non-relief commercial investment going forward? Conduct an informal poll. If key investors will exit or demand heavy discounts, the flip may not be worth it.
  4. Is the US market opportunity significantly larger than the UK? If you're marginal on the decision, the tax and complexity overhead tips toward "stay in the UK." If the US market is 10x+ larger and essential to your strategy, the flip is worth the friction.
  5. Can I keep any UK operating activity or IP generation? If you can maintain genuine UK operations (R&D, customer service, IP licensing), you leave the door open for future UK fundraising or grants without triggering a full non-residency story.
  6. Do I have the budget and bandwidth for dual tax compliance? Post-flip, you'll file tax returns in both the US (federal and state) and the UK. That's complexity and cost. Budget £15k–£50k annually for accounting and tax advice, depending on your scale.

Forward-Looking Analysis: The Future of SEIS/EIS and Transatlantic Startups

The SEIS and EIS regimes are now 20+ years old (EIS) and have been tweaked several times, but the core structure remains unchanged: UK tax relief for UK companies. As more UK founders scale globally and seek US capital, there's an emerging policy question: should the UK government extend SEIS/EIS relief to UK-incorporated companies operating offshore, or to founder-led companies that flip to the US?

So far, there's little appetite in HM Treasury or HMRC to do so. The schemes are designed to retain capital and companies in the UK, not to subsidize offshore migration. If anything, HMRC has tightened the definition of "UK trade" and "UK residency" in recent years.

However, there's a secondary trend: the rise of successor schemesGrowth Investments Scheme (GIS) to potentially replace EIS for later-stage companies, and there's discussion of making it more flexible for globally-headquartered companies. As of early 2026, no new legislation has been passed, but the conversation is alive in policy circles.

For founders now, the lesson is: if you're planning a US flip within 3–5 years, disclose it upfront to your early-stage investors. Price in the loss of tax relief. Work with a specialist tax advisor to minimize clawback risk. And consider timing your flip to align with the 3-year mark after your last SEIS/EIS funding round. Transparency and planning beat last-minute scrambling every time.

The transatlantic flip is legally and tax-feasibly possible, but it requires intent and sophistication. It's not a "free" outcome; it costs in complexity, tax compliance, and investor negotiation. Make sure the US opportunity justifies the cost before you commit.